Jama Elmi currently serves as a Development Scientist at Oxford Pharmaceuticals, LLC, where he plays a pivotal role in advancing the company’s mission to provide affordable, high-quality generic drug products that enhance patient outcomes. With a robust background in government regulatory agencies, Jama possesses a...
Jama Elmi currently serves as a Development Scientist at Oxford Pharmaceuticals, LLC, where he plays a pivotal role in advancing the company’s mission to provide affordable, high-quality generic drug products that enhance patient outcomes. With a robust background in government regulatory agencies, Jama possesses a comprehensive understanding of critical regulatory standards, including cGMP, 21 CFR §211, and various international guidelines such as ICH, EMA, and WHO. His expertise ensures that all development processes adhere to stringent compliance requirements, thereby safeguarding product integrity and patient safety.
At Oxford Pharmaceuticals, Jama is actively involved in key projects that focus on the formulation and optimization of generic drug products. His proficiency in Good Laboratory Practices (GLP) and process validation is instrumental in streamlining development workflows and enhancing operational efficiencies. Utilizing advanced computer programs such as LIMS and Excel, he conducts thorough data analysis, statistical evaluations, and chromatographic data processing, which are essential for making informed decisions throughout the drug development lifecycle.
Jama’s strong foundation in organic chemistry and biotechnology further complements his role, enabling him to contribute to innovative purification techniques and formulation strategies. His commitment to continuous improvement is reflected in his adeptness with Corrective and Preventive Actions (CAPA), ensuring that any deviations are promptly addressed and resolved. With a keen eye for detail and a passion for pharmaceutical development, Jama Elmi is dedicated to driving excellence at Oxford Pharmaceuticals, ultimately contributing to the betterment of patient health and well-being.
